Cross-disease transcriptomic screening identifies fibroblast-associated mediators shared across periodontitis and rheumatoid arthritis

Key Points

• Shared mediators were identified in both conditions, indicating possible common pathways.
• Key mediators included specific fibroblast markers that could influence both diseases.
• Analysis involved transcriptomic screening to uncover common fibroblast-related elements.
• Implications for targeting these mediators in treatment strategies for both periodontitis and rheumatoid arthritis.